Beaney, T. http://orcid.org/0000-0001-9709-7264
Neves, A. L.
Alboksmaty, A.
Ashrafian, H. http://orcid.org/0000-0003-1668-0672
Flott, K.
Fowler, A.
Benger, J. R.
Aylin, P.
Elkin, S.
Darzi, A. http://orcid.org/0000-0001-7815-7989
Clarke, J. http://orcid.org/0000-0003-1495-7746
Funding for this research was provided by:
DH | National Institute for Health Research
Wellcome Trust (215938/Z/19/Z)
NHS England NHS Improvement
Article History
Received: 21 December 2021
Accepted: 4 April 2022
First Online: 29 April 2022
Competing interests
: H.A. is Chief Scientific Officer, Preemptive Medicine and Health Security at Flagship Pioneering. S.E. has received fees for an educational lecture sponsored by Astra Zeneca and is co-clinical director for the NHS England and Improvement London Respiratory Network. J.C. has received fees from Philips UK Limited for consultancy services outside of the submitted work. All other authors declare no competing interests.